The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis
Posted Apr 19 2010 12:35am
Research, the leading business intelligence provider, has released its latest research “The Future of Global Vaccines - Market Forecasts to 2015, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis”, which provides insights on the global vaccines sales, volume and price forecasts to 2015. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global vaccines market. The report analyzes the markets for vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
The scope of this report includes:
• Annualized market data for the global vaccines market from 2000 to 2008, forecast forward to 2015. • Analysis of the metabolic disorder therapeutics market in the leading geographies of the world. This includes the US, the UK, Germany, France, Italy, Spain, and Japan • Market characterization data on the global vaccines market including market size, market share and annual cost of vaccination. • Key drivers and restraints that have a significant impact on the market • Competitive landscape of the global vaccines market. The key companies studied in this report are Novartis AG, Sanofi Pasteur, Merck & Co, GlaxoSmithKline and Pfizer Inc. • Key M&A activities and licensing agreements that have taken place between 2008 and 2009 in the global vaccines market.